Aibo Medical Robot raises RMB 100 million Series A
Aibo Medical Robot raised RMB 100 million in Series A funding to advance vascular-intervention robotics and commercialisation.
Evidence notes
- Guozhong Capital led the round.
- Lenovo Capital reinvested and Changling Capital participated.
- The Shenzhen company was developing robot-assisted vascular intervention systems.
Company context
Aibo Medical Robot, also branded Abrobo, develops robotic systems for vascular intervention. The Shenzhen company integrates catheter manipulation, imaging workflow and remote-control technologies to reduce clinician radiation exposure and improve procedural precision.